Received: |
by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 17.0) with spool id
2139234 for [log in para visualizar]; Mon, 12 May 2025
14:34:54 +0200
from mx07-006a4e02.pphosted.com (mx07-006a4e02.pphosted.com
[143.55.146.78]) by listserv.backend.rediris.es (Postfix) with ESMTP
id 86B1C455F5 for < [log in para visualizar]>; Mon, 12 May 2025
14:32:14 +0200 (CEST)
from pps.filterd (m0316689.ppops.net [127.0.0.1]) by
m0316689.ppops.net (8.18.1.2/8.18.1.2) with ESMTP id 54CA5Acj014006
for < [log in para visualizar]>; Mon, 12 May 2025 14:32:14 +0200
from satellite02.sim.rediris.es (satellite02.sim.rediris.es
[130.206.24.61]) by m0316689.ppops.net (PPS) with ESMTPS id
46ke0v3f8d-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384
bits=256 verify=NOT) for < [log in para visualizar]>; Mon, 12
May 2025 14:32:13 +0200 (MEST)
from satellite02.sim.rediris.es (localhost.localdomain [127.0.0.1])
by satellite02.sim.rediris.es (Postfix) with ESMTPS id 5509EC017F for
< [log in para visualizar]>; Mon, 12 May 2025 14:32:13 +0200
(CEST)
from localhost (localhost.localdomain [127.0.0.1]) by
satellite02.sim.rediris.es (Postfix) with ESMTP id 44078C0181 for
< [log in para visualizar]>; Mon, 12 May 2025 14:32:13 +0200
(CEST)
from satellite02.sim.rediris.es ([127.0.0.1]) by localhost
(satellite02.sim.rediris.es [127.0.0.1]) (amavis,
port 10026) with ESMTP id 5nzP8ezJ9q7f for
< [log in para visualizar]>; Mon, 12 May 2025 14:32:13 +0200
(CEST)
from web-node01.backend.rediris.es (web-node01.backend.rediris.es
[130.206.25.31]) by satellite02.sim.rediris.es (Postfix) with ESMTP
id 2D4CAC017F for < [log in para visualizar]>; Mon, 12 May 2025
14:32:13 +0200 (CEST)
by web-node01.backend.rediris.es (Postfix,
from userid 48) id 1F4A6F0E6; Mon, 12 May 2025 14:32:13 +0200 (CEST) |
X-CLX-Response: |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 |
X-Authority-Analysis: |
v=2.4 cv=bJUWIO+Z c=1 sm=1 tr=0 ts=6821ea4d cx=c_pps
a=+Fh61PVTp1QmpyDL492Fzw==:117
a=+Fh61PVTp1QmpyDL492Fzw==:17
a=7E+Lg0hS2erdyBn295RJLQjl35E=:19 a=IkcTkHD0fZMA:10
a=dt9VzEwgFbYA:10 a=JL-7mqT1AAAA:8 a=9BVq-b4JAAAA:8
a=-Q5n1w3TCOka-4aTA6wA:9 a=3ZKOabzyN94A:10
a=QEXdDO2ut3YA:10 a=bITuC7i-eOZCYVAMA1Qg:22 |
Date: |
Mon, 12 May 2025 14:32:13 +0200 |
Reply-To: |
|
Approved-By: |
|
Message-ID: |
|
MIME-Version: |
1.0 |
X-Proofpoint-Spam-Details-Enc: |
AW1haW4tMjUwNTEyMDEzMSBTYWx0ZWRfX8TkLyFirIdjc
W/kAjs1MLqew2P+NvPmFCWBCbCzn0qu8cJsBvZ5fOzPhSU83AWBe/z1A1EzNsf8b4jORWrqKkXF
IFzxEECK8l8xk6w66q5kLyUA6u6gATfwTjQpcnYzYKno+VbW9ufxhyTUfQ3OJ0AWa6IGL+Ru2YO
aFdmp00cMnVNC9UYhYjU72hbxiTQRDRiRKVZMtb7PZ8MeH2FZYeyh5Ns28XTmn9WN52NxCgmWgn
I1qE2J5x78Sg40i8b4JTmJIGhpsO+QETqDveuNh1oItdjchaTRCL7iwMAXlk9zKJV8Yb9pyrdF0
fN2OeyqRmLpVPbI4sE7hT2mDa3U8KvIPC/GoHLF1lTl3b+M11YGqfdYgqI9OyGoEgLAztrrTu69
q9dKB4hMDuUT+X61jqB38BV9cBOP4A02ipcfVhsPaIidulB21pYNNb8Zkui08rc1D/qUZbZZav4
Ci0Bidne2pzUKKQ9SjJEWSMhm5DGVK0eEI6nEbjaQGCqXVgl7dcSWL9B/Uh80 |
Subject: |
|
Emisor: |
|
Sender: |
|
X-CLX-Shades: |
Deliver |
X-Amavis-Modified: |
Mail body modified (using disclaimer) -
satellite02.sim.rediris.es |
Delivered-To: |
|
X-Proofpoint-ORIG-GUID: |
HLGdnFuU9DQI4n0Mld8_KaopXCTpImv3 |
Content-Type: |
text/plain; charset=UTF-8; |
X-Proofpoint-Spam-Details: |
rule=politica_listserv_notspam
policy=politica_listserv score=0 malwarescore=0
mlxlogscore=999 clxscore=1000 impostorscore=0
adultscore=0 priorityscore=1000 phishscore=0
lowpriorityscore=0 mlxscore=0 suspectscore=0
spamscore=0 bulkscore=0 classifier=customer_allow
authscore=0 authtc=n/a authcc= route=internal
adjust=0 reason=mlx scancount=1
engine=8.19.0-2504070000 definitions=main-2505120131
domainage_hfrom=1728 |
X-Proofpoint-Virus-Version: |
vendor=baseguard
engine=ICAP:2.0.293,Aquarius:18.0.1099,Hydra:6.0.736,FMLib:17.12.80.40
definitions=2025-05-12_04,2025-05-09_01,2025-02-21_01 |
X-Proofpoint-GUID: |
HLGdnFuU9DQI4n0Mld8_KaopXCTpImv3 |
Parts/Attachments: |
|
|
===
Para darse de ALTA/BAJA del Boletin OFER-TRABEC utilice el siguiente enlace o pongase en contacto con [log in para visualizar]
https://listserv.rediris.es/cgi-bin/wa?SUBED1=OFER-TRABEC&A=1
===
SEGURIDAD: Los enlaces contenidos en este mensaje son seguros y protegidos con reescritura de URL_DEFENSE de Proofpoint
===
---Procedencia:
Institución:Universidad de Zaragoza (BIFI)
Contacto correo-e:[log in para visualizar]
---
Call for Expressions of Interest – Marie Skłodowska-Curie Postdoctoral Fellowships 2025
The European Union has launched the 2025 call for Marie Skłodowska-Curie Postdoctoral Fellowships (MSCA-PF). We are seeking a highly motivated postdoctoral candidate interested in applying for this competitive fellowship in our research group, led by Dr. Ramón Hurtado-Guerrero at the Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza.
The proposed research will focus on:
• Understanding the molecular mechanisms of GalNAc-T isoenzymes, with the aim of discovering selective inhibitors to combat diseases such as cancer.
• Developing antibodies against Tn/STn antigens for cancer immunotherapy.
Candidates with complementary project ideas within these themes are also encouraged to apply. The projects will be carried out in collaboration with internationally recognized groups, including:
• Henrik Clausen (University of Copenhagen)
• Jesús Angulo (University of Sevilla)
• Ben Schumann (Francis Crick Institute)
• Jennifer Munkley (Newcastle University)
For further information on the MSCA-PF 2025 call, please visit:
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-MSCA-2025-PF-01-01
Application Details:
Interested candidates should send the following documents by 15th July 2025:
• A detailed CV including a list of publications during the PhD and postdoctoral periods.
• A motivation letter outlining your interest in the project and relevant expertise.
Applicants must hold a PhD in Biochemistry, Chemistry, Pharmacy, or Veterinary Science, and demonstrate a strong interest in structural biology and computational approaches (e.g., protein design and molecular modeling).
Please send your application to:
Dr. Ramón Hurtado-Guerrero
[log in para visualizar]
AREA of Biophysics – BIFI, University of Zaragoza
https://www.bifi.es/biophysics/
Selected Recent Publications from Our Group:
• Sanz-Martínez et al., Accounts of Chemical Research (2023) [10.1021/acs.accounts.2c00723]
• Piniello et al., Nature Communications (2023) [10.1038/s41467-023-41238-1]
• Narimatsu et al., Nature Catalysis (2024) [10.1038/s41929-024-01116-5]
• Redrado-Hernández et al., Angewandte Chemie (2024, VIP, accepted)
• Taleb et al., Nature Communications (2022) [10.1038/s41467-022-32021-9]
• González-Ramírez et al., Nature Communications (2022) [10.1038/s41467-022-29833-0]
• García-García et al., ACS Catalysis (2021) [10.1021/acscatal.1c01698]
• Martínez-Sáez et al., Chemical Science (2016) [10.1039/C5SC04039F]
…and many more in Nature Chem Biol, JACS, ACS Cent Sci, Angew. Chemie, and Curr Opin Struct Biol.
We welcome outstanding and enthusiastic candidates from all nationalities to join a dynamic and collaborative research environment. If you're passionate about glycobiology, structural biochemistry, and translational applications in cancer, we look forward to hearing from you.
----------------
Información complementaria de la oferta:
Selected Recent Publications from Our Group:
• Sanz-Martínez et al., Accounts of Chemical Research (2023) [10.1021/acs.accounts.2c00723]
• Piniello et al., Nature Communications (2023) [10.1038/s41467-023-41238-1]
• Narimatsu et al., Nature Catalysis (2024) [10.1038/s41929-024-01116-5]
• Redrado-Hernández et al., Angewandte Chemie (2024, VIP, accepted)
• Taleb et al., Nature Communications (2022) [10.1038/s41467-022-32021-9]
• González-Ramírez et al., Nature Communications (2022) [10.1038/s41467-022-29833-0]
• García-García et al., ACS Catalysis (2021) [10.1021/acscatal.1c01698]
• Martínez-Sáez et al., Chemical Science (2016) [10.1039/C5SC04039F]
…and many more in Nature Chem Biol, JACS, ACS Cent Sci, Angew. Chemie, and Curr Opin Struct Biol.
|